Alphatec Holdings 2025 Q2 Earnings Narrower EPS Loss Despite Growing Net Loss

Alphatec Holdings (ATEC) reported its fiscal 2025 Q2 earnings on Jul 31st, 2025. The company saw a 27.5% increase in revenue, totaling $185.54 million, up from $145.57 million in the previous year's Q2. Alphatec raised its full-year revenue guidance, expecting 21% growth to approximately $742 million. The adjusted EBITDA is anticipated to reach $83 million, up from the previous estimate of $78 million. Despite the revenue growth, the net loss widened by 1.1% to $41.14 million, with an EPS loss narrower at $0.27 compared to $0.29 per share in the prior year, indicating a slight improvement in per-share loss.

Revenue

Alphatec Holdings reported a significant revenue increase of 27.5%, reaching $185.54 million in Q2 2025, compared to $145.57 million in Q2 2024. The entire revenue was derived from products and services.

Earnings/Net Income

Alphatec Holdings posted a narrower loss of $0.27 per share in Q2 2025, down from a $0.29 per share loss in the same quarter of 2024. Despite this progress, the company reported a net loss of $41.14 million, an increase from the $40.68 million loss in 2024 Q2, reflecting continuing financial challenges.

Post-Earnings Price Action Review

The strategy of buying Alphatec Holdings shares after a revenue increase on the financial report release date and holding them for 30 days has yielded a 36.69% return over the past three years. However, this outcome fell short of the benchmark return of 85.57%, resulting in an excess return of -48.88% and a compound annual growth rate (CAGR) of 6.50%. The strategy experienced a maximum drawdown of 0.00%, highlighting its volatility, which stood at 61.69%. Despite the revenue growth, the stock's performance suggests that it underperformed relative to the broader market, indicating potential investor concerns over the company's long-term financial health and strategic direction.

CEO Commentary

“I’m proud of the ATEC Family for executing yet another strong quarter,” said Pat Miles, Chairman and Chief Executive Officer. He highlighted that six years of uninterrupted industry-leading growth demonstrates the spine market's demand for ATEC's solutions. Amid industry disruptions, ATEC remains focused on architecting procedural innovations that enhance clinical outcomes. The investments made in their ecosystem are starting to show notable influence, leading to sustainable growth that exceeds market rates and signifies a financial inflection point. ATEC is committed to revolutionizing the spine surgery market rather than merely participating in it.

Guidance

For the fiscal year ending December 31, 2025, the Company now expects total revenue to grow 21% to approximately $742 million, including surgical revenue of $666 million and EOS revenue of $76 million. Additionally, the Company anticipates non-GAAP adjusted EBITDA to reach about $83 million, an increase from the previous estimate of $78 million.

Additional News

In recent company developments, Alphatec Holdings announced the appointment of new board members as part of a strategic initiative to enhance governance and leadership. This move aims to leverage their expertise to guide the company through its next phase of growth. Additionally, Alphatec is making strides in its research and development efforts, focusing on expanding its product portfolio to address unmet needs in the spine surgery market. The company has also entered into strategic partnerships with leading medical institutions to advance clinical research, reflecting its commitment to innovation and improving surgical outcomes. These initiatives are expected to strengthen Alphatec's market position and drive long-term growth.